|
1
|
Duncan JS, Sander JW, Sisodiya SM and
Walker MC: Adult epilepsy. Lancet. 367:1087–1100. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tegelberg S, Kopra O, Joensuu T, Cooper JD
and Lehesjoki AE: Early microglial activation precedes neuronal
loss in the brain of the Cstb-/- mouse model of progressive
myoclonus epilepsy, EPM1. J Neuropathol Exp Neurol. 71:40–53. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Graaf KL, Barth S, Herrmann MM, Storch
MK, Otto C, Olsson T, Melms A, Jung G, Wiesmüller KH and Weissert
R: MHC class II isotype- and allele-specific attenuation of
experimental autoimmune encephalomyelitis. J Immunol.
173:2792–2802. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Casas C, Herrandograbulosa M, Manzano R,
Mancuso R, Osta R and Navarro X: Early presymptomatic cholinergic
dysfunction in a murine model of amyotrophic lateral sclerosis.
Brain Behav. 3:145–158. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vardjan N, Gabrijel M, Potokar M, Svajger
U, Kreft M, Jeras M, de Pablo Y, Faiz M, Pekny M and Zorec R:
IFN-γ-induced increase in the mobility of MHC class II compartments
in astrocytes depends on intermediate filaments. J
Neuroinflammation. 9:1442012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beach TG, Woodhurst WB, Macdonald DB and
Jones MW: Reactive microglia in hippocampal sclerosis associated
with human temporal lobe epilepsy. Neurosci Lett. 191:27–30. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Depboylu C, Stricker S, Ghobril JP, Oertel
WH, Priller J and Höglinger GU: Brain-resident microglia
predominate over infiltrating myeloid cells in activation,
phagocytosis and interaction with T-lymphocytes in the MPTP mouse
model of Parkinson disease. Exp Neurol. 238:183–191. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wojtera M, Sobów T, Kłoszewska I, Liberski
PP, Brown DR and Sikorska B: Expression of immunohistochemical
markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's
disease: Morphometric study and review of the literature. Folia
Neuropathol. 50:74–84. 2012.PubMed/NCBI
|
|
9
|
Marinova-Mutafchieva L, Sadeghian M, Broom
L, Davis JB, Medhurst AD and Dexter DT: Relationship between
microglial activation and dopaminergic neuronal loss in the
substantia nigra: A time course study in a 6-hydroxydopamine model
of Parkinson's disease. J Neurochem. 110:966–975. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakahara H, Konishi Y, Beach TG, Yamada N,
Makino S and Tooyama I: Infiltration of T lymphocytes and
expression of icam-1 in the hippocampus of patients with
hippocampal sclerosis. Acta Histochem Cytochem. 43:157–162. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shaw JA, Perry VH and Mellanby J: MHC
class II expression by microglia in tetanus toxin-induced
experimental epilepsy in the rat. Neuropathol Appl Neurobiol.
20:392–398. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao X, Cush JJ, Garret M and Lipsky PE: A
phase I study of ethyl acetate extract of the chinese antirheumatic
herb Tripterygium wilfordii hook F in rheumatoid arthritis. J
Rheumatol. 28:2160–2167. 2001.PubMed/NCBI
|
|
13
|
Du F, Liu T, Liu T, Wang Y, Wan Y and Xing
J: Metabolite identification of triptolide by data-dependent
accurate mass spectrometric analysis in combination with online
hydrogen/deuterium exchange and multiple data-mining techniques.
Rapid Commun Mass Spectrom. 25:3167–3177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gu WZ, Chen R, Brandwein S, Mcalpine J and
Burres N: Isolation, purification, and characterization of
immunosuppressive compounds from tripterygium: Triptolide and
tripdiolide. Int J Immunopharmacol. 17:351–356. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li FQ, Lu XZ, Liang XB, Zhou HF, Xue B,
Liu XY, Niu DB, Han JS and Wang XM: Triptolide, a Chinese herbal
extract, protects dopaminergic neurons from inflammation-mediated
damage through inhibition of microglial activation. J Neuroimmunol.
148:24–31. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiao J, Xue B, Zhang L, Gong Y, Li K, Wang
H, Jing L, Xie J and Wang X: Triptolide inhibits
amyloid-beta1-42-induced TNF-alpha and IL-1beta production in
cultured rat microglia. J Neuroimmunol. 205:32–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Y, Sun Z, Zeng CQ and Gao S: Effect of
triptolide on the expression of MHC molecules on microglia of
kainite-induced rat brain. J Liaoning Univ. 14:112–114. 2012.(In
Chinese).
|
|
18
|
Kreutzberg GW: Microglia: A sensor for
pathological events in the CNS. Trends Neurosci. 19:312–318. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ponomarev ED, Novikova M, Maresz K,
Shriver LP and Dittel BN: Development of a culture system that
supports adult microglial cell proliferation and maintenance in the
resting state. J Immunol Methods. 300:32–46. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li H, Liu ZH, Dai CS, Liu D and Li LS:
Triptolide inhibits proinflammatory factor-induced over-expression
of class II MHC and B7 molecules in renal tubular epithelial cells.
Acta Pharmacol Sin. 23:775–781. 2002.PubMed/NCBI
|
|
21
|
Boss JM and Jensen PE: Transcriptional
regulation of the MHC class II antigen presentation pathway. Curr
Opin Immunol. 15:105–111. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gongora C, Hose S, O'Brien TP and Sinha D:
Downregulation of class II transactivator (CIITA) expression by
synthetic cannabinoid CP55,940. Immunol Lett. 91:11–16. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang CH, Guerder S, Hong SC, van Ewijk W
and Flavell RA: Mice lacking the MHC class II transactivator
(CIITA) show tissue-specific impairment of MHC class II expression.
Immunity. 4:167–178. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nikodemova M, Watters JJ, Jackson SJ, Yang
SK and Duncan ID: Minocycline down-regulates MHC II expression in
microglia and macrophages through inhibition of IRF-1 and protein
kinase C (PKC)alpha/betaII. J Biol Chem. 282:15208–15216. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim SH, Smith CJ and Van Eldik LJ:
Importance of MAPK pathways for microglial pro-inflammatory
cytokine IL-1 beta production. Neurobiol Aging. 25:431–439. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martins I, Deshayes F, Baton F, Forget A,
Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R and
Alcaide-Loridan C: Pathologic expression of MHC class II is driven
by mitogen-activated protein kinases. Eur J Immunol. 37:788–797.
2007. View Article : Google Scholar : PubMed/NCBI
|
